---
input_text: 'Sickle Cell Disease and CKD: An Update.BACKGROUND: Sickle cell disease
  is an inherited red blood cell disorder that affects approximately 100,000 people
  in the U.S. and 25 million people worldwide. Vaso-occlusion and chronic hemolysis
  lead to dysfunction to vital organ systems, with the kidneys being among the most
  commonly affected organs. SUMMARY: Early renal manifestations include medullary
  ischemia with loss of urine concentrating ability and hyperfiltration. This can
  be followed by progressive damage characterized by persistent albuminuria and a
  decline in the estimated glomerular filtration rate. The risk of sickle nephropathy
  is greater in those with the APOL1 G1 and G2 kidney risk variants and variants in
  HMOX1 and lower in those that co-inherit alpha-thalassemia. Therapies to treat sickle
  cell disease-related kidney damage focus on sickle cell disease modifying therapies
  (e.g. hydroxyurea) or those adopted from the non-sickle cell disease kidney literature
  (e.g. renin-angiotensin-aldosterone system inhibitors), although data on their clinical
  efficacy are limited to small studies with short follow up periods. Kidney transplantation
  for end-stage kidney disease improves survival compared to hemodialysis but is underutilized
  in this patient population. KEY MESSAGES: Kidney disease is a major contributor
  to early mortality and more research is needed to understand the pathophysiology
  and to develop targeted therapies to improve kidney health in sickle cell disease.'
raw_completion_output: |-
  action: hydroxyurea; renin-angiotensin-aldosterone system inhibitors; kidney transplantation; hemodialysis
  disease: Sickle cell disease; CKD; medullary ischemia; hyperfiltration; persistent albuminuria; end-stage kidney disease
  symptom: loss of urine concentrating ability; decline in the estimated glomerular filtration rate
  action_to_disease: hydroxyurea TREATS sickle cell disease; renin-angiotensin-aldosterone system inhibitors TREAT CKD; kidney transplantation TREATS end-stage kidney disease; hemodialysis TREATS end-stage kidney disease
  action_to_symptom: 
  triples: hydroxyurea TREATS sickle cell disease; renin-angiotensin-aldosterone system inhibitors TREAT CKD; kidney transplantation TREATS end-stage kidney disease; hemodialysis TREATS end-stage kidney disease
prompt: |+
  Split the following piece of text into fields in the following format:

  subject: <the value for subject>
  predicate: <the value for predicate>
  object: <the value for object>
  qualifier: <A qualifier for the statements, e.g. "NOT" for negation>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  hemodialysis TREATS end-stage kidney disease

  ===

extracted_object:
  triples:
    - subject: hydroxyurea
      predicate: TREATS
      object: sickle cell disease
    - subject: renin-angiotensin-aldosterone system inhibitors
      predicate: TREAT
      object: CKD
    - subject: kidney transplantation
      predicate: TREATS
      object: end-stage kidney disease
    - subject: hemodialysis
      predicate: TREATS
      object: end-stage kidney disease
  action:
    - hydroxyurea
    - renin-angiotensin-aldosterone system inhibitors
    - kidney transplantation
    - MAXO:0000602
  disease:
    - MONDO:0011382
    - MONDO:0005300
    - medullary ischemia
    - hyperfiltration
    - persistent albuminuria
    - end-stage kidney disease
  symptom:
    - loss of urine concentrating ability
    - decline in the estimated glomerular filtration rate
  action_to_disease:
    - subject: hydroxyurea
      predicate: TREATS
      object:
        - MONDO:0011382
    - subject: renin-angiotensin-aldosterone system inhibitors
      predicate: TREAT
      object:
        - MONDO:0005300
    - subject: kidney transplantation
      predicate: TREATS
      object:
        - end-stage kidney disease
    - subject: MAXO:0000602
      predicate: TREATS
      object:
        - end-stage kidney disease
named_entities:
  - id: MAXO:0001001
    label: genetic therapies
  - id: MONDO:0011382
    label: sickle cell disease
  - id: MONDO:0100096
    label: COVID-19
  - id: MONDO:0005087
    label: Respiratory disease
  - id: MONDO:0007374
    label: <Sickle cell disease (SCD)
  - id: MONDO:0005632
    label: acute chest syndrome
  - id: MONDO:0005550
    label: infections
  - id: MONDO:0005081
    label: preeclampsia
  - id: MONDO:0005030
    label: intrauterine growth restriction
  - id: MONDO:0000831
    label: Thrombosis
  - id: MONDO:0005080
    label: Portal hypertension
  - id: MONDO:0005149
    label: Pulmonary Hypertension
  - id: MAXO:0000756
    label: transfusion
  - id: MAXO:0000747
    label: hematopoietic stem cell transplantation
  - id: MONDO:0005279
    label: Pulmonary embolism
  - id: HP:0025179
    label: Ground glass opacities
  - id: MAXO:0000118
    label: immunizations
  - id: HP:0001297
    label: stroke
  - id: MONDO:0002280
    label: anemia
  - id: HP:0001511
    label: intrauterine growth retardation
  - id: HP:0001518
    label: low birth weight
  - id: MAXO:0001006
    label: full blood count
  - id: MAXO:0000825
    label: reticulocyte count
  - id: MAXO:0000427
    label: brain MRI
  - id: HP:0012532
    label: chronic pain
  - id: MONDO:0005098
    label: stroke
  - id: MONDO:0005192
    label: Pancreatic cancer
  - id: MONDO:0018874
    label: Acute myeloid leukemia
  - id: MONDO:0009693
    label: Multiple myeloma
  - id: MONDO:0800385
    label: iron overload
  - id: MONDO:0005300
    label: Chronic Kidney Disease (CKD)
  - id: MONDO:0003139
    label: Mesangioproliferative Glomerulonephritis
  - id: MONDO:0006835
    label: Minimal Change Disease
  - id: MONDO:0100313
    label: Focal Segmental Glomerulosclerosis
  - id: MONDO:0001085
    label: Interstitial Nephritis
  - id: HP:0000093
    label: Proteinuria
  - id: MAXO:0000969
    label: optical coherence tomography (OCT)
  - id: HP:0000505
    label: visual impairment
  - id: MONDO:0013730
    label: acute graft-versus-host disease (GVHD)
  - id: MONDO:0100467
    label: hypertensive disorder of pregnancy
  - id: HP:0000822
    label: high blood pressure
  - id: MONDO:0005170
    label: Myeloid malignancies
  - id: MONDO:0004745
    label: priapism
  - id: HP:0012213
    label: Decreased GFR
  - id: MONDO:0005570
    label: hematologic diseases
  - id: MAXO:0010203
    label: echocardiography
  - id: HP:0012531
    label: Pain
  - id: MAXO:0000536
    label: <Chorionic villus sampling (CVS)
  - id: MONDO:0011399
    label: Alpha thalassemia
  - id: MONDO:0019402
    label: Beta thalassemia
  - id: MONDO:0000984
    label: Thalassemia
  - id: MONDO:0043544
    label: Nosocomial infections
  - id: MAXO:0001479
    label: allogeneic hematopoietic stem cell transplantation
  - id: MAXO:0000571
    label: CT
  - id: MONDO:0007145
    label: Aplasia cutis congenita
  - id: MONDO:0005246
    label: Osteomyelitis
  - id: MONDO:0020517
    label: Eosinophilic granuloma
  - id: MAXO:0000447
    label: Surgical removal
  - id: HP:0000989
    label: Pruritus
  - id: MAXO:0000149
    label: myeloablative, matched sibling donor hematopoietic stem cell transplant
      (HCT)
  - id: MAXO:0001175
    label: liver transplantation
  - id: MONDO:0006955
    label: Rheumatic heart disease
  - id: MONDO:0005147
    label: Type 1 diabetes
  - id: MAXO:0000602
    label: hemodialysis
